Haleon EBITDA 2023-2024 | HLN
Haleon annual and quarterly EBITDA history from 2023 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Haleon EBITDA for the quarter ending September 30, 2024 was $0.917B, a 0% increase year-over-year.
- Haleon EBITDA for the twelve months ending September 30, 2024 was $3.248B, a 0% increase year-over-year.
- Haleon 2024 annual EBITDA was $3.233B, a 12.76% increase from 2023.
- Haleon 2023 annual EBITDA was $2.867B, a 9.76% increase from 2022.
- Haleon 2022 annual EBITDA was $2.612B, a 0% decline from 2021.
| Haleon Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $3,233 |
| 2023 | $2,867 |
| 2022 | $2,612 |
| 2021 | $0 |
| Haleon Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $917 |
| 2024-03-31 | $831 |
| 2023-09-30 | $739 |
| 2023-03-31 | $762 |
| 2022-12-31 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $43.571B | $14.355B |
| Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.007B | 26.38 |
| Boston Scientific (BSX) | United States | $154.324B | 36.80 |
| Stryker (SYK) | United States | $144.711B | 29.46 |
| EssilorLuxottica (ESLOY) | France | $142.399B | 0.00 |
| Medtronic (MDT) | Ireland | $117.900B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.114B | 0.00 |
| ResMed (RMD) | United States | $41.687B | 29.81 |
| Agilent Technologies (A) | United States | $33.767B | 22.01 |
| GE HealthCare Technologies (GEHC) | United States | $33.630B | 15.81 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $26.220B | 17.34 |
| Insulet (PODD) | United States | $22.229B | 74.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.230B | 12.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.039B | 0.00 |
| Baxter (BAX) | United States | $12.558B | 9.70 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.773B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.704B | 10.01 |
| Envista Holdings (NVST) | United States | $3.460B | 24.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.179B | 14.10 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $2.762B | 18.81 |
| Haemonetics (HAE) | United States | $2.521B | 11.25 |
| LeMaitre Vascular (LMAT) | United States | $2.169B | 46.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.969B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.827B | 78.46 |
| QuidelOrtho (QDEL) | United States | $1.762B | 11.09 |
| AtriCure (ATRC) | United States | $1.760B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.299B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.84 |
| BioLife Solutions (BLFS) | United States | $1.213B | 2532.00 |
| Neogen (NEOG) | United States | $1.195B | 18.97 |
| Acuren (TIC) | United States | $1.153B | 0.00 |
| InMode (INMD) | Israel | $0.903B | 8.35 |
| Valneva SE (VALN) | France | $0.891B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.820B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| SNDL (SNDL) | Canada | $0.554B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.543B | 0.00 |
| Surmodics (SRDX) | United States | $0.538B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| Cresco Labs (CRLBF) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.447B | 15.40 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.417B | 3.70 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.357B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.356B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Omeros (OMER) | United States | $0.254B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 49.35 |
| Vireo Growth (VREOF) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.209B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 15.21 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.67 |
| Biote (BTMD) | United States | $0.147B | 4.89 |
| TriSalus Life Sciences (TLSI) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.14 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.080B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 35.37 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Veru (VERU) | United States | $0.054B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 33.33 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |